scholarly article | Q13442814 |
P356 | DOI | 10.1074/JBC.271.48.30879 |
P698 | PubMed publication ID | 8940072 |
P2093 | author name string | R W Gross | |
M J Wolf | |||
P2860 | cites work | Human myocardial cytosolic Ca(2+)-independent phospholipase A2 is modulated by ATP. Concordant ATP-induced alterations in enzyme kinetics and mechanism-based inhibition | Q42792277 |
Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction | Q25938986 | ||
Crystal structure of a mammalian phosphoinositide-specific phospholipase C delta | Q27732615 | ||
Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes | Q27860623 | ||
A novel arachidonic acid-selective cytosolic PLA2 contains a Ca(2+)-dependent translocation domain with homology to PKC and GAP | Q28302244 | ||
Interfacial properties and critical micelle concentration of lysophospholipids | Q31033714 | ||
Purification of a 110-kilodalton cytosolic phospholipase A2 from the human monocytic cell line U937. | Q33826817 | ||
10 Monolayer culture techniques | Q39240003 | ||
Translocation of the 85-kDa phospholipase A2 from cytosol to the nuclear envelope in rat basophilic leukemia cells stimulated with calcium ionophore or IgE/antigen | Q41333836 | ||
Inhibition of macrophage Ca(2+)-independent phospholipase A2 by bromoenol lactone and trifluoromethyl ketones. | Q41381528 | ||
Use of bacteriophage T7 lysozyme to improve an inducible T7 expression system | Q42476169 | ||
P433 | issue | 48 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 30879-30885 | |
P577 | publication date | 1996-11-01 | |
P1433 | published in | Journal of Biological Chemistry | Q867727 |
P1476 | title | Expression, purification, and kinetic characterization of a recombinant 80-kDa intracellular calcium-independent phospholipase A2. | |
P478 | volume | 271 |
Q44733406 | A novel mechanism for the store-operated calcium influx pathway |
Q40790369 | A pyrrolidine-based specific inhibitor of cytosolic phospholipase A(2)alpha blocks arachidonic acid release in a variety of mammalian cells |
Q34569098 | Activation mechanism for CRAC current and store-operated Ca2+ entry: calcium influx factor and Ca2+-independent phospholipase A2beta-mediated pathway |
Q46644010 | Activation of calcium-independent phospholipase A (iPLA) in brain mitochondria and release of apoptogenic factors by BAX and truncated BID. |
Q35922450 | Activation of mitochondrial calcium-independent phospholipase A2γ (iPLA2γ) by divalent cations mediating arachidonate release and production of downstream eicosanoids |
Q42454789 | Agonist-specific alterations in receptor-phospholipase coupling following inactivation of Gi2alpha gene |
Q38722497 | Analyses of Calcium-Independent Phospholipase A2beta (iPLA2β) in Biological Systems |
Q74028246 | Ca2+ -independent cytosolic phospholipase A in HL-60 cells differentiating to granulocytes |
Q77942934 | Calcium-independent phospholipase A2 in isolated rabbit ventricular myocytes |
Q35994344 | Calcium-independent phospholipases A2 and their roles in biological processes and diseases. |
Q37199186 | Calcium-independent phospholipases in the heart: mediators of cellular signaling, bioenergetics, and ischemia-induced electrophysiologic dysfunction |
Q33707768 | Catalytic Function of PLA2G6 Is Impaired by Mutations Associated with Infantile Neuroaxonal Dystrophy but Not Dystonia-Parkinsonism |
Q31135290 | Characterization of N-terminal processing of group VIA phospholipase A2 and of potential cleavage sites of amyloid precursor protein constructs by automated identification of signature peptides in LC/MS/MS analyses of proteolytic digests |
Q77461423 | Characterization of acidic Ca(2+)-independent phospholipase A2 of bovine lung |
Q32066822 | Cloning and expression of a group IV cytosolic Ca2+-dependent phospholipase A2 from rat pancreatic islets. Comparison of the expressed activity with that of an islet group VI cytosolic Ca2+-independent phospholipase A2. |
Q28578474 | Cloning and expression of cDNA encoding rat liver 60-kDa lysophospholipase containing an asparaginase-like region and ankyrin repeat |
Q41110642 | Cloning, expression, and catalytic mechanism of murine lysophospholipase I. |
Q42469975 | Differential potentiation of arachidonic acid release by rat alpha2 adrenergic receptor subtypes |
Q42037362 | Effects of biological oxidants on the catalytic activity and structure of group VIA phospholipase A2 |
Q37462762 | Establishment of an improved mouse model for infantile neuroaxonal dystrophy that shows early disease onset and bears a point mutation in Pla2g6. |
Q28613265 | Evidence that phospholipase A2 activity is required for Golgi complex and trans Golgi network membrane tubulation |
Q42136740 | Fluoroketone inhibition of Ca(2+)-independent phospholipase A2 through binding pocket association defined by hydrogen/deuterium exchange and molecular dynamics |
Q33886495 | Group VIA Ca2+-independent phospholipase A2 (iPLA2beta) and its role in beta-cell programmed cell death |
Q28569210 | Group VIA phospholipase A2 forms a signaling complex with the calcium/calmodulin-dependent protein kinase IIbeta expressed in pancreatic islet beta-cells |
Q33238930 | Highly selective hydrolysis of fatty acyl-CoAs by calcium-independent phospholipase A2beta. Enzyme autoacylation and acyl-CoA-mediated reversal of calmodulin inhibition of phospholipase A2 activity |
Q28139679 | Human Pancreatic Islets Express mRNA Species Encoding Two Distinct Catalytically Active Isoforms of Group VI Phospholipase A2 (iPLA2) [etc.] |
Q31705755 | Identification of the calmodulin-binding domain of recombinant calcium-independent phospholipase A2beta. implications for structure and function |
Q34050555 | Inhibition of Ca2+-independent phospholipase A2 results in insufficient insulin secretion and impaired glucose tolerance |
Q33306605 | Inhibition of calcium-independent phospholipase A impairs agonist-induced calcium entry in keratinocytes. |
Q42236378 | Inhibition of mitochondrial calcium-independent phospholipase A2 (iPLA2) attenuates mitochondrial phospholipid loss and is cardioprotective |
Q33704434 | Inhibitors of intracellular phospholipase A2 activity: their neurochemical effects and therapeutical importance for neurological disorders |
Q35641753 | Islet complex lipids: involvement in the actions of group VIA calcium-independent phospholipase A(2) in beta-cells |
Q36027388 | Loss of PLA2G6 leads to elevated mitochondrial lipid peroxidation and mitochondrial dysfunction |
Q41554056 | Lysophosphatidic acid as a phospholipid mediator: pathways of synthesis |
Q33681195 | Mammalian lysophospholipases. |
Q37027268 | Mechanism-based inhibition of iPLA2β demonstrates a highly reactive cysteine residue (C651) that interacts with the active site: mass spectrometric elucidation of the mechanisms underlying inhibition |
Q30496535 | Mitochondrial dysfunction and reduced prostaglandin synthesis in skeletal muscle of Group VIB Ca2+-independent phospholipase A2gamma-deficient mice |
Q91410759 | Molecular insights into the sex-differential regulation of signal transduction in the cerebral ganglion and metabolism in the hepatopancreas of Eriocheir sinensis during reproduction |
Q42478631 | N-terminal and C-terminal plasma membrane anchoring modulate differently agonist-induced activation of cytosolic phospholipase A2. |
Q32142261 | Naegleria fowleri amoebae express a membrane-associated calcium-independent phospholipase A(2). |
Q52691735 | Orai, STIM1 and iPLA2beta: a view from a different perspective. |
Q38830281 | Phospholipase A2 as a Molecular Determinant of Store-Operated Calcium Entry. |
Q26997377 | Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention |
Q48143750 | Prostaglandin synthesis in rat brain astrocytes is under the control of the n-3 docosahexaenoic acid, released by group VIB calcium-independent phospholipase A2. |
Q24531330 | Purification and characterization of a lysophosphatidic acid-specific phosphatase |
Q33257525 | Regulation of store-operated calcium entry by calcium-independent phospholipase A2 in rat cerebellar astrocytes. |
Q38892312 | Regulation of the Ca(2+)-independent phospholipase A2 in liver mitochondria by changes in the energetic state. |
Q37240112 | Skeletal muscle group VIA phospholipase A2 (iPLA2beta): expression and role in fatty acid oxidation |
Q38498393 | Smooth muscle cell arachidonic acid release, migration, and proliferation are markedly attenuated in mice null for calcium-independent phospholipase A2beta |
Q35048741 | Spinal phospholipase A2 in inflammatory hyperalgesia: role of group IVA cPLA2 |
Q43908137 | Stimulation of insulin secretion and associated nuclear accumulation of iPLA(2)beta in INS-1 insulinoma cells |
Q95840299 | Substantia nigra echogenicity is associated with serum ferritin, gender and iron-related genes in Parkinson's disease |
Q39715315 | Substrate efflux propensity is the key determinant of Ca2+-independent phospholipase A-β (iPLAβ)-mediated glycerophospholipid hydrolysis |
Q22253411 | The genomic organization, complete mRNA sequence, cloning, and expression of a novel human intracellular membrane-associated calcium-independent phospholipase A(2) |
Q34348429 | The molecular biology of the group VIA Ca2+-independent phospholipase A2. |
Q50282174 | The structure of iPLA2β reveals dimeric active sites and suggests mechanisms of regulation and localization |
Q35189288 | iPLA2β knockout mouse, a genetic model for progressive human motor disorders, develops age-related neuropathology |
Q28252165 | The highly selective production of 2-arachidonoyl lysophosphatidylcholine catalyzed by purified calcium-independent phospholipase A2gamma: identification of a novel enzymatic mediator for the generation of a key branch point intermediate in eicosano |
Search more.